Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ravi Salgia D Ross Camidge James G Christensen Benjamin J Solomon Kristin Bergethon Jeffrey W Clark Eunice L Kwak Yung-Jue Bang Keith D Wilner A John Iafrate Robert G. Maki Sai-Hong Ignatius Ou |
| Publication date | May 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |